Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.21B
Revenue (ttm)	886.92M
Net Income (ttm)	76.52M
Shares Out	961.94M
EPS (ttm)	0.08
PE Ratio	15.83
Forward PE	12.96
Dividend	0.03 (2.38%)
Ex-Dividend Date	Sep 8, 2025

Volume	193,600
Average Volume	522,740
Open	1.270
Previous Close	1.260
Day's Range	1.260 - 1.290
52-Week Range	1.070 - 1.460
Beta	0.31
RSI	42.28
Earnings Date	Nov 7, 2025

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2024, Duopharma Biotech Berhad's revenue was 813.70 million, an increase of 15.46% compared to the previous year's 704.73 million. Earnings were 62.65 million, an increase of 19.00%.